A Clinical Study of Xin'an Medicine in the Treatment of Bi Syndrome

NACompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Xinfeng capsule

Xinfeng capsule:Three each time, 3 times a day, Oral,for 3 months; placebo(for leflunomide):10mg each time, 1 time a day, Oral,for 3 months; Participants will continue on the stable dose of glucocorticoids and NSAIDs that they were receiving prior to study entry

DRUG

leflunomide

leflunomide :10mg each time, one time a day, Oral,for 3 months; placebo(for xinfeng capsule):Three each time, 3 times a day, Oral,for 3 months; Participants will continue on the stable dose of glucocorticoids and NSAIDs that they were receiving prior to study entry

Trial Locations (3)

230031

The first affiliated hospital of anhui medical university, Hefei

233004

The first affiliated hospital of bengbu medical college, Bengbu

241001

Yijishan Hospital of Wannan Medical College, Wuhu

All Listed Sponsors
collaborator

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV

lead

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

OTHER

NCT01774877 - A Clinical Study of Xin'an Medicine in the Treatment of Bi Syndrome | Biotech Hunter | Biotech Hunter